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Abstract
In treating cholesterol-related cardiovascular diseases,
statins are commonly used as preventative medication
and are associated with few side effects. However, recent
studies have described a connection between statins and
development of tendinopathy. Similar research has noted
bilateral rupture of the Achilles tendon, a rare injury, in
patients undergoing statin therapy. We describe a 74-yearold man undergoing statin (ie, simvastatin) therapy who
presented with pain and swelling in the right ankle after
exertional-type activity. Magnetic resonance imaging
confirmed a rupture of the Achilles tendon, with rupture
of the left Achilles tendon identified 5 weeks later without
any obvious trauma-related event. Nonoperative treatment
included nonweight bearing in short-leg casts, physical
therapy, and eventual temporary discontinuation of
simvastatin therapy, which resulted in full return to previous
levels of activity by 6-month follow-up. Orthopaedic
surgeons should be aware of potential musculoskeletalrelated side effects in patients undergoing statin therapy.

Introduction
Rupture of the Achilles tendon is common and generally
occurs in weakened tendons and after high-impact
force, particularly in men aged 30 to 50 years who play
exertional-type sports intermittently.1 On the other hand,
bilateral tendon rupture is rare and may indicate systemicrelated causes.2 These injuries have been associated with
renal transplantation,3 systemic lupus erythematosus,4
rheumatoid arthritis,5 fluoroquinolone use,2 and systemic
or locally injected steroid.6,7
Recent case reports and retrospective analyses have
also noted statin therapy as a possible cause of tendon
rupture, specifically in the Achilles tendon.8 Statins are
commonly administered as preventative treatment of
cholesterol-related cardiovascular disease.9 Although statin
therapy has generally been considered safe with few side
effects, musculoskeletal toxicity and myopathy have been
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reported.10 We present a 74-year-old man undergoing statin
therapy with ruptures of both Achilles tendons, in whom
no traditional risk factor for tendinopathy was noted. By
6-month follow-up, the patient returned to previous levels
of activity after undergoing nonoperative treatment such as
nonweight-bearing short-leg casts and physical therapy.

Case Report
A 74-year-old man presented to our clinic with pain in
the right ankle and a soft ankle brace, having injured his
Achilles tendon 9 days earlier after lunging forward in
a game of pickle ball. He described the resultant feeling
as if he “was hit in the back of the ankle with a two-byfour.” He did not have history of autoimmune disease, had
not undergone an organ transplant, and did not recently
undergo steroid or fluoroquinolone therapy. The patient
was undergoing simvastatin therapy, with doses of 20 mg
per day for treating hyperlipidemia.
No palpable gap was noted in the Achilles tendon with
the patient in prone position, but swelling was observed in
the region. Results of the Thompson test were positive for a
torn tendon. Notably, the results of the Thompson test were
negative for tears in the left Achilles tendon and the patient
had no complaints of left-sided pain. Magnetic resonance
imaging (MRI) revealed a ruptured Achilles tendon without
retraction (Figure 1A). After discussing risks and benefits

Figure 1A. Magnetic resonance imaging of the right ankle at 9
days after initial injury, showing rupture of the right Achilles
tendon.

between nonoperative and operative treatment methods,
the patient elected to use nonoperative techniques. His right
ankle was placed into a nonweight-bearing short-leg cast in
slight equinus position.
At 3 weeks after initial injury, the patient begun to
develop pain in his left Achilles tendon. He suspected the
pain resulted from overuse owing to the nonweight-bearing
status of his right lower extremity. Increased strength of
the right lower extremity was observed during right ankle
plantarflexion, and use of a short-leg cast was continued.
At 4 weeks after the initial injury, the right Achilles
tendon had improved union without any particular
swelling on physical examination, and plantar flexion of the
ankle against resistance could be performed comfortably
with moderate strength. In the left lower extremity, mild
swelling was noted, with tenderness around the posterior
ankle and Achilles tendon. The tendon seemed to be intact
with palpation, with improved strength in plantarflexion.
Owing to concern for possible rupture, an MRI was ordered.
Until the MRI was obtained, both lower extremities were
placed into walking boots with heel lifts.
At 5-week follow-up, findings of the MRI indicated
an Achilles tendon rupture of the left ankle (Figure 1B).
A short-leg cast was placed on the left lower extremity,
whereas the right lower extremity was transitioned into
weight bearing with passive range of motion exercises. The
concern of statin therapy associated with tendinopathy was
discussed with the patient and relayed to his primary care
physician. The patient decided to temporarily discontinue
statin therapy while the Achilles tendons healed.
At 3 and 2 months after right and left Achilles tendon
ruptures, respectively, the patient stopped using walking
boots and transitioned into lace-up ankle braces for
comfort. Physical therapy was initiated for gait training and
progressive strengthening of both lower extremities.

At 6 months after his initial right-sided injury, the
patient walked similarly to before the injury and returned
to previous levels of daily activity, without use of the brace
or other nonweight-bearing devices.

Discussion
To date, no precise mechanism for bilateral rupture of
the Achilles tendon has been identified, and the causal
relationship between statin therapy and tendinopathy is
still in question. A postmarket analysis8 reported statinassociated tendinopathy (with the Achilles tendon being
the most affected) in a small proportion of patients (2.1%)
administered low-density lipoprotein. Furthermore, results
of another retrospective study11 indicated no significant
increase in tendinopathy among patients undergoing
statin therapy compared with age-matched control groups.
However, biochemical studies on rodents have reported
definite change in the chemical makeup of tendons exposed
to prolonged use of statin.12
Multiple theories have been suggested for explaining
statin-related tendon toxicity, including decreased
angiogenesis and vascularization,13 reduced cholesterol
content of cell membranes,11 and imbalance of matrix
metalloproteinases and eicosanoids.14 To our knowledge, one
case report15 has described bilateral Achilles tendon rupture
and attributed the injury to statin therapy because no other
risk factors were identified. Two studies have reported more
generally on bilateral quadriceps tendon rupture indirectly
associated with statin therapy.16,17 Notably, in the current
study, the rare occurrence of metasynchronous bilateral
Achilles tendon rupture was noted without identifiable
systemic risk factors, and the second rupture involved no
apparent trauma-related event.
Although the relationship between statin therapy and
tendinous injury remains unclear, orthopaedic surgeons
and primary care physicians should consider potential
risk for musculoskeletal side effects in patients undergoing
statin therapy. In avoiding tendon-type injuries, caution
should be taken in prescribing statin for patients with higher
risks for tendinous disorders (ie, patients with concomitant
fluoroquinolone therapy, high-intensity muscular activity,
and healing tendinous injuries).
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